TEVA Trading Analysis - 09/16/2026 01:41 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a new generic version of a popular medication, expanding its portfolio of affordable treatment options.
• The company received FDA approval for a new indication of one of its key products, broadening its market reach.
• TEVA reported a significant increase in sales for its flagship medication, attributing the growth to strong market demand and effective marketing strategies.

These headlines suggest a positive outlook for TEVA, with the company expanding its product offerings, receiving regulatory approvals, and experiencing sales growth. This context supports a bullish technical and sentiment analysis.

Fundamental Analysis:

Based on the provided fundamentals data:

• Total Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margins: 64.41%
• Operating Margins: 11.36%
• Profit Margins: 5.03%

The fundamentals indicate:

• TEVA has a high trailing P/E of 65.42, suggesting potential overvaluation.
• The debt-to-equity ratio is high at 4.14, which could be a concern.
• ROE is positive at 9.14%, indicating effective use of shareholder capital.
• The profit margins are relatively healthy, with a gross margin of 64.41% and operating margin of 11.36%.

Overall, while there are some concerns regarding valuation and leverage, the company's profitability and growth potential appear strong.

Current Market Position:

Current price: $38.90

Recent price action:

• The stock has shown an uptrend, with the price increasing from $34.72 on 2026-08-05 to $38.90 on 2026-09-16.
• The recent intraday momentum is positive, with the price reaching a high of $39.52 on 2026-09-14.

Technical Analysis:

SMA trends:

• SMA 5: $38.06
• SMA 20: $37.26
• SMA 50: $35.12

The short-term SMA 5 and SMA 20 are above the SMA 50, indicating a bullish trend.

Indicators:

• RSI 14: 55.61
• MACD: 0.75 (above signal line)
• Bollinger Bands: Middle band $37.26, Upper band $39.06, Lower band $35.46

The RSI is neutral, MACD is bullish, and the price is near the upper Bollinger Band, suggesting potential for further upside but also increased volatility.

30-day high/low context: The stock is near its 30-day high, indicating strong recent performance.

True Sentiment Analysis (Delta 40-60 Options):

Overall sentiment: Bullish

Call vs Put dollar volume:

• Call dollar volume: $3,505,333
• Put dollar volume: $18,070

The sentiment analysis is strongly bullish, with a significant call-to-put dollar volume ratio, indicating near-term expectations for the stock price to increase.

Key Price Levels:

Support levels: $37.26 (SMA 20), $35.12 (SMA 50)

Resistance levels: $39.06 (upper Bollinger Band), $40.00 (psychological level)

25-Day Price Forecast:

TEVA is projected for $40.50 to $42.20 in 25 days, based on current trends, momentum, and indicators.

The projection considers:

• Continued bullish trend from SMA and RSI.
• MACD indicating potential for further gains.
• Recent volatility (ATR 14: 1.22) and support/resistance levels.

Defined Risk Strategy Recommendations:

Based on the 25-day forecast of $40.50 to $42.20:

• Bull Call Spread: Buy TEVA 261009C00039000 (strike $39.00, price $1.24) and sell TEVA 261009C00041000 (strike $41.00, price $0.16). Net debit: $1.08. Max profit: $0.92. Breakeven: $40.08.
• Iron Condor: Sell TEVA 261009C00040000 (strike $40.00, price $0.89) and buy TEVA 261009C00042000 (strike $42.00, price $0.39), while selling TEVA 261009P00038000 (strike $38.00, price $1.36) and buying TEVA 261009P00036000 (strike $36.00, price $0.92). This strategy benefits from a range-bound market.

Risk Factors:

• Technical warning signs: Overbought conditions could lead to a pullback.
• Sentiment divergences: A sudden shift in options sentiment could impact the stock price.
• Volatility: Increased ATR could affect the performance of defined risk strategies.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA shows bullish momentum with strong institutional buying and positive sentiment analysis.